TAM
AUTL

TFG Asset Management’s Autolus Therapeutics AUTL Stock Holding History

TFG Asset Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Hold
9,500,000
– – 2.39% 3
2026
Q1 		$13.1M Hold
9,500,000
– – 2.55% 7
2025
Q4 		$18.9M Hold
9,500,000
– – 3.99% 4
2025
Q3 		$15.5M Hold
9,500,000
– – 2.07% 11
2025
Q2 		$21.7M Buy
9,500,000
+900,000
+10% +$1.49M 3.49% 5
2025
Q1 		$13.3M Buy
8,600,000
+350,000
+4% +$711K 3.04% 8
2024
Q4 		$19.4M Buy
8,250,000
+250,000
+3% +$845K 4.95% 5
2024
Q3 		$29M Hold
8,000,000
– – 8.19% 4
2024
Q2 		$27.8M Buy
8,000,000
+474,318
+6% +$2.05M 6.94% 4
2024
Q1 		$48M Sell
7,525,682
-474,318
-6% -$2.96M 10.88% 3
2023
Q4 		$51.5M Sell
8,000,000
-4,000,000
-33% -$15.3M 12.41% 2
2023
Q3 		$28M Hold
12,000,000
– – 5.1% 6
2023
Q2 		$28.6M Buy
12,000,000
+2,000,000
+20% +$4.75M 3.86% 8
2023
Q1 		$18.4M Buy
10,000,000
+1,700,000
+20% +$3.32M 2.46% 12
2022
Q4 		$15.8M Buy
8,300,000
+5,260,619
+173% +$13.3M 2.26% 16
2022
Q3 		$6.5M Buy
3,039,381
+19,968
+0.7% +$59.2K 0.78% 31
2022
Q2 		$8.54M Buy
3,019,413
+193,476
+7% +$589K 0.59% 44
2022
Q1 		$11.8M Buy
2,825,937
+125,937
+5% +$530K 0.53% 39
2021
Q4 		$14M Buy
2,700,000
+200,000
+8% +$1.2M 0.84% 28
2021
Q3 		$16.4M Hold
2,500,000
– – 1% 26
2021
Q2 		$16.6M Buy
2,500,000
+64,286
+3% +$399K 0.9% 27
2021
Q1 		$14M Buy
2,435,714
+285,714
+13% +$2.11M 1% 21
2020
Q4 		$19.2M Hold
2,150,000
– – 1.29% 18
2020
Q3 		$25M Hold
2,150,000
– – 2.3% 12
2020
Q2 		$34.5M Buy
2,150,000
+167,399
+8% +$1.86M 4.59% 9
2020
Q1 		$11.9M Buy
1,982,601
+682,601
+53% +$6.31M 2.06% 15
2019
Q4 		$17.2M Hold
1,300,000
– – 2.55% 15
2019
Q3 		$16.1M Buy
1,300,000
+300,000
+30% +$3.97M 2.88% 12
2019
Q2 		$16.1M Buy
1,000,000
+148,369
+17% +$3.32M 2.34% 13
2019
Q1 		$26.8M Buy
851,631
+51,631
+6% +$1.47M 3.33% 14
2018
Q4 		$26.3M Buy
800,000
+9,850
+1% +$324K 4.14% 9
2018
Q3 		$24.2M Buy
790,150
+765,150
+3,061% +$20.7M 2.9% 13
2018
Q2 		$670K Buy
+25,000
New +$661K 0.09% 45

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TFG Asset Management's AUTL Position: Q2 2026 in Review

TFG Asset Management held its Autolus Therapeutics (AUTL) position steady in Q2 2026 at 9,500,000 shares worth $15.2M. The position accounts for 2.39% of the portfolio, ranked #3.

TFG Asset Management first reported a position in AUTL in Q2 2018 and has held it in 33 quarters since. The position peaked at $51.5M in Q4 2023. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • TFG Asset Management held 9,500,000 shares of Autolus Therapeutics worth $15.2M as of Q2 2026.
  • TFG Asset Management left its Autolus Therapeutics share count unchanged in Q2 2026.
  • Autolus Therapeutics made up 2.39% of TFG Asset Management's portfolio in Q2 2026, its #3 holding.
  • TFG Asset Management first reported a position in Autolus Therapeutics in Q2 2018 and has held it in 33 quarters since.
  • TFG Asset Management's Autolus Therapeutics position peaked at $51.5M in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.